Glycated albumin as a diagnostic tool for diabetes mellitus in transfusion-dependent β-thalassemia patients
Endocrine · 2025
DOI: 10.1007/s12020-025-04410-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine, 2025. Verfasst von Gianluca Marzi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology, Geriatrics and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy. Hauptthemen laut MEDLINE: Serum Albumin, beta-Thalassemia, Diabetes Mellitus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Ferrara.
Themen: Diabetes mellitus
Abstract (Originalsprache)
INTRODUCTION: β-thalassemia is an inherited hemoglobinopathy which, in severe cases, requires lifelong transfusions, leading to iron overload and increases risk of metabolic complications, including diabetes mellitus. The standard glycemic marker, glycated hemoglobin, is unreliable in transfusion-dependent patients due to altered erythrocyte turnover. This study investigates the possible utility of glycated albumin as an alternative biomarker for diagnosing glucose metabolism disorders in transfusion-dependent patients. METHODS: A cross-sectional analysis was conducted on 254 transfusion-dependent patients followed at the Center for Hemoglobinopathies and Thalassemia at Ferrara Hospital, evaluating Glycated Albumin levels, fasting plasma glucose, oral glucose tolerance test results, and iron overload assessed by Magnetic Resonance Imaging. RESULTS: Glycated Albumin levels significantly correlated with Fasting Plasma Glucose (r = 0.710, p < 0.01), Oral Glucose Tolerance Test glucose levels at 60 and 120 min, and the area under the glycemic curve (p < 0.01). ROC curve analysis identified a Glycated Albumin cutoff of 14.95% for Diabetes Mellitus diagnosis, with a sensitivity of 93.1% and specificity of 89.1%. Glycated Albumin correlated with hepatic and heart iron accumulation but not with pancreatic iron overload. CONCLUSIONS: These findings indicate Glycated Albumin as a promising marker for glycemic assessment in transfusion-dependent patients, warranting further validation in multicenter studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Endocrinology, Geriatrics and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
- Unit of Endocrinology and Metabolic Diseases, Department of Specialty Medicine, Azienda Ospedaliero Universitaria S.Anna, Ferrara, Italy.
- Day Hospital of Thalassemia and Hemoglobinopathies, Department of Specialty Medicine, Azienda Ospedaliero Universitaria S. Anna, Ferrara, Italy.
- Integrated Activity Department, Imaging and Laboratory Diagnostics, Clinical Pathology, Azienda Ospedaliero Universitaria S. Anna, Ferrara, Italy.
- Radiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy.
- Section of Endocrinology, Geriatrics and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy. mbrmrs@unife.it.
Förderung
- Università degli Studi di Ferrara
Zitieren
APA
Marzi, G., Verrienti, M., Longo, F., Cattaneo, C. A., Gobbo, A., Vetralla, K., Franzè, G. P., Cossu, A., Culcasi, M., Zatelli, M. C., & Ambrosio, M. R. (2025). Glycated albumin as a diagnostic tool for diabetes mellitus in transfusion-dependent β-thalassemia patients. Endocrine. https://doi.org/10.1007/s12020-025-04410-9
Vancouver
Marzi G, Verrienti M, Longo F, Cattaneo CA, Gobbo A, Vetralla K, et al. Glycated albumin as a diagnostic tool for diabetes mellitus in transfusion-dependent β-thalassemia patients. Endocrine. 2025. doi:10.1007/s12020-025-04410-9
BibTeX
@article{Marzi2025,
author = {Marzi, Gianluca and Verrienti, Martina and Longo, Filomena and Cattaneo, Camilla Alice and Gobbo, Alberto and Vetralla, Katalin and Franzè, Gian Pietro and Cossu, Alberto and Culcasi, Martina and Zatelli, Maria Chiara and Ambrosio, Maria Rosaria},
title = {Glycated albumin as a diagnostic tool for diabetes mellitus in transfusion-dependent β-thalassemia patients},
journal = {Endocrine},
year = {2025},
doi = {10.1007/s12020-025-04410-9}
}
EUVIMED